Antibodies, produced early in disease and persisting throughout, are promising tools for early diagnosis and treatment optimization. Sengenics protein microarrays have revealed antibody biomarkers across diverse diseases, including autoimmune, neuroinflammatory, cancer, and infectious diseases.
Discover how Sengenics technology can advance your disease research.
